Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (1-10 of 10,640) with videos related to

Pageof 1,064
Sort By:
Current Pharmaceutical Design|July 23, 2003
Pharmacophore discovery--lessons learnedJohn H van Drie
Current Pharmaceutical Design|July 23, 2003
Inhibitors of the proteolytic activity of urokinase type plasminogen activatorTodd W Rockway, Vincent L Giranda
Current Pharmaceutical Design|July 23, 2003
Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodelingSteingrimur Stefansson, Grainne A McMahon, Eric Petitclerc, et al.
Current Pharmaceutical Design|July 23, 2003
Urokinase receptor and integrin interactionsMatthias C Kugler, Ying Wei, Harold A Chapman
Current Pharmaceutical Design|July 23, 2003
Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effectsL Amati, L Caradonna, G Leandro, et al.
Current Pharmaceutical Design|July 23, 2003
Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel diseaseGiuseppe Famularo, Luciana Mosca, Giovanni Minisola, et al.
Current Pharmaceutical Design|July 23, 2003
Gene therapy of cancer with interleukin-12Guillermo Mazzolini, Jesús Prieto, Ignacio Melero
Current Pharmaceutical Design|July 23, 2003
BLyS: the pivotal determinant of peripheral B cell selection and lifespanSusan Harless Smith, Michael P Cancro
Current Pharmaceutical Design|July 23, 2003
Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implicationsAlejandro Ruiz-Argüelles, Liliana Rivadeneyra-Espinoza, Donato Alarcón-Segovia
Current Pharmaceutical Design|July 23, 2003
Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivativesL Douali, D Villemin, D Cherqaoui
Pageof 1,064

Showing results (1-10 of 10,640) with videos related to

Sort By:
Pageof 1,064
Current Pharmaceutical Design|July 23, 2003
Pharmacophore discovery--lessons learnedJohn H van Drie
Current Pharmaceutical Design|July 23, 2003
Inhibitors of the proteolytic activity of urokinase type plasminogen activatorTodd W Rockway, Vincent L Giranda
Current Pharmaceutical Design|July 23, 2003
Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodelingSteingrimur Stefansson, Grainne A McMahon, Eric Petitclerc, et al.
Current Pharmaceutical Design|July 23, 2003
Urokinase receptor and integrin interactionsMatthias C Kugler, Ying Wei, Harold A Chapman
Current Pharmaceutical Design|July 23, 2003
Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effectsL Amati, L Caradonna, G Leandro, et al.
Current Pharmaceutical Design|July 23, 2003
Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel diseaseGiuseppe Famularo, Luciana Mosca, Giovanni Minisola, et al.
Current Pharmaceutical Design|July 23, 2003
Gene therapy of cancer with interleukin-12Guillermo Mazzolini, Jesús Prieto, Ignacio Melero
Current Pharmaceutical Design|July 23, 2003
BLyS: the pivotal determinant of peripheral B cell selection and lifespanSusan Harless Smith, Michael P Cancro
Current Pharmaceutical Design|July 23, 2003
Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implicationsAlejandro Ruiz-Argüelles, Liliana Rivadeneyra-Espinoza, Donato Alarcón-Segovia
Current Pharmaceutical Design|July 23, 2003
Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivativesL Douali, D Villemin, D Cherqaoui
Pageof 1,064